Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 16, 2009
Reporting Period: Fiscal fourth quarter and full year ended May 31, 2009.
This filing serves to announce the issuance of a press release containing financial results for the specified period. The document explicitly states that the financial information contained herein is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The provided text is a cover sheet and legal framework for the 8-K filing. It references a press release (Exhibit 99.1) containing the actual data but does not include the specific numerical values within this text.
- Revenue: Not provided in this text.
- Profit: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific comparative data or material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for year-over-year or quarter-over-quarter performance analysis.
Guidance, Outlook, and Risks
Forward-Looking Statements: The document contains a comprehensive disclaimer regarding forward-looking statements. These statements are based on current expectations and involve significant risks and uncertainties.
Identified Risks and Uncertainties:
- Economic, credit, and capital market conditions affecting the general economy and medical device companies.
- Domestic and foreign health care reforms and governmental regulations.
- Third-party relations, approvals, and technological advances by competitors.
- Challenges in new product development, including regulatory approvals.
- Actions by the FDA or other regulatory agencies.
- Results of pending or future clinical trials.
- Outcome of pending patent litigation.
- Foreign currency exchange rate fluctuations.
- Pricing pressures from group purchasing organizations and competition.
- Integration challenges of purchased businesses.
Management Commentary: The company disclaims any obligation to update forward-looking statements and cautions investors not to place undue reliance on them.
Investor Verification Checklist
- Verify the specific revenue, net income, and earnings per share figures in the attached Press Release (Exhibit 99.1).
- Confirm the status of pending patent litigation mentioned in the risk factors.
- Review the latest Form 10-K for the fiscal year ended May 31, 2008, for detailed historical context referenced in the risk section.
- Assess the impact of current economic conditions on the medical device sector as highlighted in the forward-looking statements.
- Check for any updates on regulatory approvals for new products since the date of this filing.